Abstract:Abstract Background Biofilms formed by antibiotic-resistant bacteria in wound beds present unique challenges in terms of treating wound infections. In this work, the in vivo anti-biofilm activity of a novel electrochemical bandage (e-bandage) designed to continuously deliver low amounts of hypochlorous acid (HOCl) was evaluated against wound biofilm infections caused by a clinical isolate of Pseudomonas aeruginosa resistant to all antibiotic classes except aminoglycosides. Methods 5 mm skin wounds were created on the dorsal surface of Swiss-Webster mice and infected with 106 CFU of P. aeruginosa. Biofilms were allowed to form over 2 days, after which e-bandages with TegadermTM or Tegaderm only were placed on the wound beds. Specifically, mice were randomized to one of three experimental groups (n = 7-8): 1) Tegaderm only (control); 2) non-polarized e-bandage; 3) polarized e-bandage using a wearable potentiostat. After 48 hours, animals were sacrificed and 10 mm skin biopsies containing the wound and surrounding tissue were harvested for bacterial quantification. Histopathology was performed on H&E-stained sections of wound beds from each treatment group. Blood was screened with an inflammatory cytokine panel. Wound healing (% area reduction; digital measurement) and purulence (observational scoring) were assessed in pre- and post-treatment wounds. Results 48 hours of polarized e-bandage treatment resulted in a mean reduction of 1.86 log10 biofilm CFUs/g (p < 0.0001) vs non-polarized controls, and 2.18 log10 CFU/g reduction (p < 0.0001) vs Tegaderm only controls (polarized, 7.6 ± 0.66 log10 CFU/g; non-polarized, 9.45 ± 0.26 log+10 CFU/g; Tegaderm only, 9.78 ± 0.16 log10 CFU/g). Compared to Tegaderm only, purulence reduction and wound healing were significantly higher for both non-polarized (purulence - p < 0.0001; healing - p < 0.01 ) and polarized treatment (purulence - p < 0.0001; healing - p < 0.0001) groups, but were not significantly different from each other. Histopathology and blood inflammation panel testing showed no significant differences between groups. Conclusion An HOCl-producing e-bandage reduced P. aeruginosa in wound biofilms, representing a potential antibiotic-free strategy for the treatment of recalcitrant wound infections. Disclosures Audrey N. Schuetz, MD, Merck: Advisor/Consultant Robin Patel, MD, Abbott Laboratories: Advisor/Consultant|Adaptive Phage Therapeutics: Grant/Research Support|Adaptive Phage Therapeutics: Mayo Clinic has a royalty-bearing know-how agreement and equity in Adaptive Phage Therapeutics.|BIOFIRE: Grant/Research Support|CARB-X: Advisor/Consultant|ContraFect: Grant/Research Support|Day Zero Diagnostics: Advisor/Consultant|HealthTrackRx: Advisor/Consultant|Mammoth Biosciences: Advisor/Consultant|Netflix: Advisor/Consultant|Oxford Nanopore Technologies: Advisor/Consultant|PhAST: Advisor/Consultant|See details: Patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic|See details: continued, patent on an anti-biofilm substance issued|TenNor Therapeutics Limited: Grant/Research Support|Torus Biosystems: Advisor/Consultant|Trellis Bioscience, Inc.: Advisor/Consultant

Identification of High-Risk Lower Extremity Wounds Using Point-of-Care Test for Bacterial Protease Activity; A Single-Centre, Single-Blinded, Prospective Study

Bacterial protease activity as a biomarker to assess the risk of non-healing in chronic wounds: Results from a multicentre randomised controlled clinical trial

The detrimental impact of extracellular bacterial proteases on wound healing

A Diagnostic-Driven Prospective Clinical Study Evaluating the Combination of an Antibiofilm Agent and Negative Pressure Wound Therapy

A double-blind trial comparing an antimicrobial combination to standard care in hard-to-heal wounds

Assessing Biofilm at the Bedside: Exploring Reliable Accessible Biofilm Detection Methods

The Infected Diabetic Foot: Does Negative Pressure Wound Therapy with Irrigation Reduce Bioburden and Improve Wound Healing?

Reduction Of Biofilm In Chronic Wounds By Antibacterial Protease Combined With Silver Dressing

Association of biofilm and microbial metrics with healing rate in older adults with chronic venous leg ulcers

Association between baseline abundance of Peptoniphilus, a Gram-positive anaerobic coccus, and wound healing outcomes of DFUs

How effective is simple mechanical wound debridement in reducing bacterial colonisation? Results of a prospective clinical study

Biomarkers for the early detection of pressure ulcers in the intensive care setting: A comparison between sub‐epidermal moisture measurements and interleukin‐1α

Adaptive expression of biofilm regulators and adhesion factors of <i>Staphylococcus aureus</i> during acute wound infection under the treatment of negative pressure wound therapy <i>in vivo</i>

Prototype Development of the Intelligent Hydrogel Wound Dressing and Its Efficacy in the Detection of Model Pathogenic Wound Biofilms

Bactogram: Spatial Analysis of Bacterial Colonisation in Epidermal Wounds

2120. Activity of a Hypochlorous Acid-Generating Electrochemical Bandage for Treating Experimental Murine Wounds Infected with Pseudomonas aeruginosa

A scoping review protocol to identify clinical signs, symptoms and biomarkers indicative of biofilm presence in chronic wounds

Assessment and Monitoring of the Wound Micro-Environment in Chronic Wounds Using Standardized Wound Swabbing for Individualized Diagnostics and Targeted Interventions

Characterization of bacterial communities in venous insufficiency wounds by use of conventional culture and molecular diagnostic methods.

In Vivo Assessment of Protease Dynamics in Cutaneous Wound Healing by Degradomics Analysis of Porcine Wound Exudates

Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage: Correlation With Subsequent Postclosure Deep Wound Infection (Bioburden Study)